Librería: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Alemania
Miembro de asociación: GIAQ
EUR 14,40
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Wie neu. 276 S.; Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 910.
Librería: BookOrders, Russell, IA, Estados Unidos de America
EUR 43,23
Cantidad disponible: 1 disponibles
Añadir al carritoHard Cover. Condición: Acceptable. No Jacket. Ex-library with the usual features. The interior is clean and tight. Binding is good. Cover shows light wear. 322 pages. Ex-Library.
Idioma: Inglés
Publicado por Basel, Springer Basel., 2004
ISBN 10: 3764364351 ISBN 13: 9783764364359
Librería: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Alemania
EUR 22,00
Cantidad disponible: 1 disponibles
Añadir al carrito2004. 16 x 24 cm. XIV, 262 S. XIV, 262 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Milestones in Drug Therapy). Sprache: Englisch.
EUR 7,01
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: fine. Envoi soigné, expédition en 24h/48h.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 165,76
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 165,76
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 182,74
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New.
EUR 198,24
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Series: Milestones in Drug Therapy. Num Pages: 276 pages, biography. BIC Classification: MMG. Category: (G) General (US: Trade); (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 235 x 155 x 18. Weight in Grams: 780. . 2004. 2004th Edition. hardcover. . . . .
EUR 215,09
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 280.
EUR 218,60
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. xiv + 262 1st Edition.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel, 2012
ISBN 10: 3034895992 ISBN 13: 9783034895996
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The drugs named calcium channel blockers (CCBs) were initially termed cal cium antagonists (see Chapter 1). They are also designated as calcium entry blockers (CEBs), calcium blockers, calcium channel antagonists, calcium channel inhibitors (and in French anticalciques). As this is reported in several chapters of this book, their main effect is a blockade of calcium entry into cells through voltage operated calcium channels (VOCCs). Chemically related drugs, such as Bay K 8644, exert the opposite effect by increasing the proba bility of calcium channel opening. One of the subcommittees of the Nomenclature Committee (NC-IUPAR) of the International Union of Pharmacology has been devoted to the classification of calcium channels and the site of action of drugs modifying channel function. The members of this Committee are noted for their significant contribution to the field (Tab. 1). A report has been published in 1992 in Pharmacological Reviews [3]. A list of criteria was approved for the identification of distinct drug binding 2 sites on Ca + channels. It included: (a) the demonstration of a stereoselective binding site supported by drug interaction studies (competition with other drugs, non-competitive interactions with other sites, reversal of inhibitory effects by channel activators); (b) demonstration of the electrophysiologieal effects of the drug and selectivity of action compared to other sites; (c) deter mination of the affinity for the type and subtype of ion channel. These criteria have identified different classes of Ca antagonists (see Chapter 2).
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel, 2004
ISBN 10: 3764364351 ISBN 13: 9783764364359
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The main effect of calcium channel blockers is the blockade of calcium entry into cells through voltage operated calcium channels. This volume gives a comprehensive overview of the different classes of CCBs and their various effects. It covers historical development, pharmacology, clinical aspects, and perspectives. All chapters are written by Prof. T. Godfraind, a world leading expert in the field.
EUR 251,22
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Series: Milestones in Drug Therapy. Num Pages: 276 pages, biography. BIC Classification: MMG. Category: (G) General (US: Trade); (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 235 x 155 x 18. Weight in Grams: 780. . 2004. 2004th Edition. hardcover. . . . . Books ship from the US and Ireland.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 248,93
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Like New. Like New. book.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 248,93
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. Like New. book.
EUR 284,04
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Librería: moluna, Greven, Alemania
EUR 136,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoKartoniert / Broschiert. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive overview of the different classes of calcium channel blockers and their mode of action All chapters written by Prof. T. Godfraind, a leading expert in the fieldThe main effect of calcium channel blockers is the blockade of.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel Nov 2012, 2012
ISBN 10: 3034895992 ISBN 13: 9783034895996
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 160,49
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The drugs named calcium channel blockers (CCBs) were initially termed cal cium antagonists (see Chapter 1). They are also designated as calcium entry blockers (CEBs), calcium blockers, calcium channel antagonists, calcium channel inhibitors (and in French anticalciques). As this is reported in several chapters of this book, their main effect is a blockade of calcium entry into cells through voltage operated calcium channels (VOCCs). Chemically related drugs, such as Bay K 8644, exert the opposite effect by increasing the proba bility of calcium channel opening. One of the subcommittees of the Nomenclature Committee (NC-IUPAR) of the International Union of Pharmacology has been devoted to the classification of calcium channels and the site of action of drugs modifying channel function. The members of this Committee are noted for their significant contribution to the field (Tab. 1). A report has been published in 1992 in Pharmacological Reviews [3]. A list of criteria was approved for the identification of distinct drug binding 2 sites on Ca + channels. It included: (a) the demonstration of a stereoselective binding site supported by drug interaction studies (competition with other drugs, non-competitive interactions with other sites, reversal of inhibitory effects by channel activators); (b) demonstration of the electrophysiologieal effects of the drug and selectivity of action compared to other sites; (c) deter mination of the affinity for the type and subtype of ion channel. These criteria have identified different classes of Ca antagonists (see Chapter 2). 280 pp. Englisch.
Librería: moluna, Greven, Alemania
EUR 136,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoGebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive overview of the different classes of calcium channel blockers and their mode of action All chapters written by Prof. T. Godfraind, a leading expert in the fieldThe main effect of calcium channel blockers is the blockade of.
Librería: preigu, Osnabrück, Alemania
EUR 141,20
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Calcium Channel Blockers | Théophile Godfraind | Buch | xiv | Englisch | 2004 | Birkhäuser Basel | EAN 9783764364359 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Nov 2012, 2012
ISBN 10: 3034895992 ISBN 13: 9783034895996
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The drugs named calcium channel blockers (CCBs) were initially termed cal cium antagonists (see Chapter 1). They are also designated as calcium entry blockers (CEBs), calcium blockers, calcium channel antagonists, calcium channel inhibitors (and in French anticalciques). As this is reported in several chapters of this book, their main effect is a blockade of calcium entry into cells through voltage operated calcium channels (VOCCs). Chemically related drugs, such as Bay K 8644, exert the opposite effect by increasing the proba bility of calcium channel opening. One of the subcommittees of the Nomenclature Committee (NC-IUPAR) of the International Union of Pharmacology has been devoted to the classification of calcium channels and the site of action of drugs modifying channel function. The members of this Committee are noted for their significant contribution to the field (Tab. 1). A report has been published in 1992 in Pharmacological Reviews [3]. A list of criteria was approved for the identification of distinct drug binding 2 sites on Ca + channels. It included: (a) the demonstration of a stereoselective binding site supported by drug interaction studies (competition with other drugs, non-competitive interactions with other sites, reversal of inhibitory effects by channel activators); (b) demonstration of the electrophysiologieal effects of the drug and selectivity of action compared to other sites; (c) deter mination of the affinity for the type and subtype of ion channel. These criteria have identified different classes of Ca antagonists (see Chapter 2).Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 280 pp. Englisch.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel Mär 2004, 2004
ISBN 10: 3764364351 ISBN 13: 9783764364359
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The drugs named calcium channel blockers (CCBs) were initially termed cal cium antagonists (see Chapter 1). They are also designated as calcium entry blockers (CEBs), calcium blockers, calcium channel antagonists, calcium channel inhibitors (and in French anticalciques). As this is reported in several chapters of this book, their main effect is a blockade of calcium entry into cells through voltage operated calcium channels (VOCCs). Chemically related drugs, such as Bay K 8644, exert the opposite effect by increasing the proba bility of calcium channel opening. One of the subcommittees of the Nomenclature Committee (NC-IUPAR) of the International Union of Pharmacology has been devoted to the classification of calcium channels and the site of action of drugs modifying channel function. The members of this Committee are noted for their significant contribution to the field (Tab. 1). A report has been published in 1992 in Pharmacological Reviews [3]. A list of criteria was approved for the identification of distinct drug binding 2 sites on Ca + channels. It included: (a) the demonstration of a stereoselective binding site supported by drug interaction studies (competition with other drugs, non-competitive interactions with other sites, reversal of inhibitory effects by channel activators); (b) demonstration of the electrophysiologieal effects of the drug and selectivity of action compared to other sites; (c) deter mination of the affinity for the type and subtype of ion channel. These criteria have identified different classes of Ca antagonists (see Chapter 2).Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 280 pp. Englisch.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 228,26
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 280 Illus.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 231,60
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. xiv + 262 Illus.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 228,79
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 280.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 230,66
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. xiv + 262.